• You need to sign in or sign up before continuing.
Close
Announcements
Projects
Orgs
Project
Articles 41
Votes 0
FierceBiotech

Authors 6

Ben Adams
Helen Floersh
FierceBiotech
James Waldron
Max Bayer
Nick Paul Taylor
Celcuity's breast cancer combo hits goals, teeing up FDA filing - Fierce Biotech
22d
Recursion lays off 20% of staff in wake of pipeline cutbacks - Fierce Biotech
2mo
JPM24: Lilly CEO David Ricks to biotechs: 'We're open for business' - FierceBiotech
>1y
JPM24, Day 2: GSK, Eli Lilly, Blueprint, SR One and more - FierceBiotech
>1y
Drug more effective on pain than gabapentin, minus side effects - FierceBiotech
almost2y
Hepatitis B drug developers chart slow progress forward, just like hep C before it - FierceBiotech
almost2y
Verve shows base editing works in humans in first clinical data—and is punished by investors - FierceBiotech
almost2y
AstraZeneca's long-term GLP-1 play is weight management, not obesity, CEO says - FierceBiotech
almost2y
CRISPR-Vertex gene editing 1st gets narrow review by FDA panel - FierceBiotech
almost2y
Merck pays $4B for Daiichi ADCs in bet on post-Keytruda future - FierceBiotech
almost2y
Beam lays off 20% of staff and culls CAR-T work to save cash - FierceBiotech
almost2y
Akero's NASH miss drags a few peers down, spurring deja vu in long-challenging indication - FierceBiotech
almost2y
FDA hopes to spur stimulant use disorder drug development - FierceBiotech
almost2y
FDA's single-trial guidance calls for the good, bad and ugly data to support effectiveness - FierceBiotech
almost2y
GE HealthCare scores $44M Gates grant for AI-powered ultrasound - FierceBiotech
almost2y
RayzeBio scores $311M oversized IPO, Neumora hits $250M target - FierceBiotech
almost2y
Carl June, Vertex execs and Parkinson's scientists win Breakthrough prizes - FierceBiotech
almost2y
BMS trims anti-TIGIT and a handful of other meds - FierceBiotech
almost2y
BMS trims anti-TIGIT and a handful of other meds - FierceBiotech
almost2y
Italian billionaires behind Ferrari, Juventus drop $2.8B to become Philips' largest shareholder - FierceBiotech
~2y
One injection to cure sickle cell? Researchers give it a shot with new mRNA gene therapy - FierceBiotech
~2y
Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data - FierceBiotech
~2y
CRISPR helps solve 100-year mystery of why cancer cells have extra chromosomes - FierceBiotech
~2y
First-gen mRNA flu vaccines 'will not win,' Sanofi execs admit as they retool strategy - FierceBiotech
~2y
It's 'a concern': Bavarian Nordic flags worrying COVID-19 vaccine result ahead of phase 3 data drop - FierceBiotech
~2y